Whether the different signaling output dictated by the oligomeric conformations of HER2 in HRG-positive/HER2-negative and HRG-negative/HER2-positive breast cancer cells [60] might explain the partial overlap between their respective cytokine signatures will require further investigation. The gene discussed is ERBB2; the disease is breast cancer.